Lewis S
Health Services Utilization and Research Commission, Saskatoon, Sask.
CMAJ. 1995 Oct 15;153(8):1073-7.
The role of organizations in the development of clinical practice guidelines (CPGs) has received virtually no analytic attention. In a strictly rational and disinterested world, CPGs would be assessed on the basis of the supporting evidence and applicability to practice. However, factors that have more to do with medical sociology play a key role in CPG acceptance and, in some cases, development. The entire concept of CPGs entails troubling paradoxes, many of which turn on the distinction between scientific evidence and the sociologic determinants of validation and implementation. At the root of the question of organizational roles is the issue of values: Whose values should be at the table? What values are legitimate? From what perspectives should the utility of a procedure or technology be addressed? The Canadian health care system is a largely public creature, and CPG development is part of the public policy process. In this context, decisions about organizational roles must be sensitive to conflict of interest and a diversity of values. A provisional model for participation in CPG processes would minimize the role of organizations per se, although individual participants would no doubt reflect the legitimate interests of their affiliations without representing them formally.
组织在临床实践指南(CPG)制定过程中所扮演的角色几乎未受到分析关注。在一个严格理性且无私的世界里,CPG将依据支持证据及对实践的适用性来进行评估。然而,更多与医学社会学相关的因素在CPG的接受过程中,甚至在某些情况下在其制定过程中发挥着关键作用。CPG的整个概念包含令人困扰的悖论,其中许多悖论都围绕着科学证据与验证及实施的社会学决定因素之间的区别。组织角色问题的根源在于价值观问题:哪些人的价值观应该被考虑在内?哪些价值观是合理的?应该从哪些角度来探讨一项程序或技术的效用?加拿大医疗保健系统在很大程度上是公共性质的,CPG的制定是公共政策过程的一部分。在这种背景下,关于组织角色的决策必须对利益冲突和多种价值观保持敏感。参与CPG过程的一个暂定模式将尽量减少组织本身的作用,尽管个体参与者无疑会在不正式代表其所属机构的情况下反映其合法利益。